Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Brain Neoplasms 3Neoplasm Metastasis 2Carcinoma, Ovarian Epithelial 2Unspecified Adult Solid Tumor, Protocol Specific 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Lung Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Fallopian Tube Neoplasms 1Ependymoma 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 7Oxaliplatin 5Paclitaxel 4Fluorouracil 4Carboplatin 4Albumin-Bound Paclitaxel 4Taxes 3Mitomycin 3130-nm albumin-bound paclitaxel 3Nivolumab 2Leucovorin 2Doxorubicin 2veliparib 1tremelimumab 1talimogene laherparepvec 1soluble LAG-3 protein, human 1sodium thiosulfate 1pembrolizumab 1nintedanib 1irinotecan sucrosofate 1durvalumab 1dehydroftorafur 1cc-486 1avelumab 1Trastuzumab 1Semaxinib 1Radiotherapy 1Radiation 1Platinum 1Pharmacogenomic Variants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Peritoneal Neoplasms × Chromatography, Liquid × Clear all
NCT00825201 2018-01-19

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

City of Hope Medical Center

Phase 1 Completed
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡